These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27510401)

  • 21. Foxp3+ cells control Th2 responses in a murine model of atopic dermatitis.
    Fyhrquist N; Lehtimäki S; Lahl K; Savinko T; Lappeteläinen AM; Sparwasser T; Wolff H; Lauerma A; Alenius H
    J Invest Dermatol; 2012 Jun; 132(6):1672-80. PubMed ID: 22402436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical application of a vitamin D analogue exacerbates atopic dermatitis and induces the atopic dermatitis-like phenotype in Stat6VT mice.
    Turner MJ; Dasilva-Arnold SC; Yi Q; Mehrotra P; Kaplan MH; Travers JB
    Pediatr Dermatol; 2013; 30(5):574-8. PubMed ID: 23889122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.
    Spergel JM; Mizoguchi E; Oettgen H; Bhan AK; Geha RS
    J Clin Invest; 1999 Apr; 103(8):1103-11. PubMed ID: 10207161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17.
    Nakagawa R; Yoshida H; Asakawa M; Tamiya T; Inoue N; Morita R; Inoue H; Nakao A; Yoshimura A
    J Immunol; 2011 Nov; 187(9):4611-20. PubMed ID: 21957150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitinase 3-like 1 drives allergic skin inflammation via Th2 immunity and M2 macrophage activation.
    Kwak EJ; Hong JY; Kim MN; Kim SY; Kim SH; Park CO; Kim KW; Lee CG; Elias JA; Jee HM; Sohn MH
    Clin Exp Allergy; 2019 Nov; 49(11):1464-1474. PubMed ID: 31397016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions.
    Hennino A; Vocanson M; Toussaint Y; Rodet K; Benetière J; Schmitt AM; Aries MF; Bérard F; Rozières A; Nicolas JF
    J Immunol; 2007 May; 178(9):5571-7. PubMed ID: 17442939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atopic dermatitis: immunobiology and treatment with immune modulators.
    Leung DY
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():25-30. PubMed ID: 9020932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis.
    Newell L; Polak ME; Perera J; Owen C; Boyd P; Pickard C; Howarth PH; Healy E; Holloway JW; Friedmann PS; Ardern-Jones MR
    J Invest Dermatol; 2013 Oct; 133(10):2372-2380. PubMed ID: 23528819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.
    Correa da Rosa J; Malajian D; Shemer A; Rozenblit M; Dhingra N; Czarnowicki T; Khattri S; Ungar B; Finney R; Xu H; Zheng X; Estrada YD; Peng X; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Mar; 135(3):712-20. PubMed ID: 25583101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epicutaneous sensitization with superantigen induces allergic skin inflammation.
    Laouini D; Kawamoto S; Yalcindag A; Bryce P; Mizoguchi E; Oettgen H; Geha RS
    J Allergy Clin Immunol; 2003 Nov; 112(5):981-7. PubMed ID: 14610492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness.
    Schlotter YM; Rutten VP; Riemers FM; Knol EF; Willemse T
    Vet Immunol Immunopathol; 2011 Sep; 143(1-2):20-6. PubMed ID: 21684616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Th2 systemic immune milieu enhances cutaneous inflammation in the K14-IL-4-transgenic atopic dermatitis model.
    Reichle ME; Chen L; Lin SX; Chan LS
    J Invest Dermatol; 2011 Mar; 131(3):791-4. PubMed ID: 21191418
    [No Abstract]   [Full Text] [Related]  

  • 33. Administration of poly(I:C) improved dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice by the regulation of Th1/Th2 balance.
    Kim CH; Park CD; Lee AY
    Vaccine; 2012 Mar; 30(14):2405-10. PubMed ID: 22119586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiopathogenesis of atopic dermatitis--an overview.
    Pastar Z; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2005; 13(1):54-62. PubMed ID: 15788148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and pharmacologic modulation of the granulocyte-associated allergic responses to ovalbumin in murine skin models induced by injecting ovalbumin-specific Th1 or Th2 cells.
    Terui T; Sano K; Okada M; Shirota H; Honda M; Ozawa M; Hirasawa N; Tamura G; Tagami H
    J Invest Dermatol; 2001 Aug; 117(2):236-43. PubMed ID: 11511299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma.
    Lee GR; Flavell RA
    Int Immunol; 2004 Aug; 16(8):1155-60. PubMed ID: 15226271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adaptive immune system in atopic dermatitis and implications on therapy.
    Roesner LM; Werfel T; Heratizadeh A
    Expert Rev Clin Immunol; 2016 Jul; 12(7):787-96. PubMed ID: 26967382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.
    Moosbrugger-Martinz V; Tripp CH; Clausen BE; Schmuth M; Dubrac S
    J Cell Mol Med; 2016 May; 20(5):930-8. PubMed ID: 26931745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mouse models for spontaneous dermatitis due to impaired skin barrier formation].
    Sasaki T; Shiohama A; Amagai M
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(3):160-5. PubMed ID: 24974928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
    Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.